Published in J Hypertens on February 01, 2005
Effect of Arginine Supplementation in the Metabolic Syndrome | NCT02354794
Characterization of the Metabolic Fate of an Oral Arginine Form | NCT02352740
Diabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic inflammation. Environ Health Perspect (2006) 3.23
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia (2010) 3.17
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes (2007) 2.19
Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation (2009) 2.09
Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care (2009) 1.91
Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension (2010) 1.77
Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci (2014) 1.41
The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol (2012) 1.35
Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol (2009) 1.27
Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med (2010) 1.25
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? Arterioscler Thromb Vasc Biol (2012) 1.19
Brain cytokines as neuromodulators in cardiovascular control. Clin Exp Pharmacol Physiol (2009) 1.18
Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J Sex Med (2008) 1.15
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam (2014) 1.13
Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide (2012) 1.10
Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07
Endothelial cell-specific liver kinase B1 deletion causes endothelial dysfunction and hypertension in mice in vivo. Circulation (2014) 1.05
Human endothelial dysfunction: EDRFs. Pflugers Arch (2010) 1.04
The association of reproductive history with all-cause and cardiovascular mortality in older women: the Rancho Bernardo Study. Fertil Steril (2011) 0.96
A review of the safety and efficacy of nebivolol in the mildly hypertensive patient. Vasc Health Risk Manag (2007) 0.93
Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler Thromb Vasc Biol (2012) 0.93
Racial differences in nitric oxide-dependent vasorelaxation. Reprod Sci (2008) 0.92
The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. Kidney Int Suppl (2011) (2011) 0.91
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J Cell Mol Med (2008) 0.90
Functional imaging of working memory and peripheral endothelial function in middle-aged adults. Brain Cogn (2010) 0.89
p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity. Cardiovasc Diabetol (2014) 0.89
Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol (2006) 0.89
Gas what: NO is not the only answer to sexual function. Br J Pharmacol (2014) 0.89
A randomized trial of exercise for blood pressure reduction in type 2 diabetes: effect on flow-mediated dilation and circulating biomarkers of endothelial function. Atherosclerosis (2012) 0.88
High resolution imaging of vascular function in zebrafish. PLoS One (2012) 0.88
Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice. J Clin Invest (2012) 0.88
Cardiovascular risk in patients with psoriatic arthritis. Int J Rheumatol (2012) 0.88
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme. Vasc Health Risk Manag (2007) 0.87
Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol (2015) 0.87
Human endothelial dysfunction: EDCFs. Pflugers Arch (2010) 0.86
Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming. Front Pharmacol (2014) 0.86
Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag (2008) 0.86
Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology (2014) 0.85
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus. BMC Cardiovasc Disord (2016) 0.84
Association of ATP1B1, RGS5 and SELE polymorphisms with hypertension and blood pressure in African-Americans. J Hypertens (2011) 0.84
Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. Clin Res Cardiol (2014) 0.84
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil. Vasc Health Risk Manag (2011) 0.84
Peripheral vascular dysfunction in migraine: a review. J Headache Pain (2013) 0.83
Role of SIRT3 in Angiotensin II-induced human umbilical vein endothelial cells dysfunction. BMC Cardiovasc Disord (2015) 0.83
Insulin resistance is an independent determinate of ED in young adult men. PLoS One (2013) 0.82
Scavenging free radicals improves endothelial dysfunction in human coronary arteries in vivo. Heart Vessels (2010) 0.81
Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms. Br J Pharmacol (2015) 0.81
Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries. Am J Physiol Heart Circ Physiol (2012) 0.81
Bradykinin or acetylcholine as vasodilators to test endothelial venous function in healthy subjects. Clinics (Sao Paulo) (2008) 0.81
A control systems approach to quantify wall shear stress normalization by flow-mediated dilation in the brachial artery. PLoS One (2015) 0.80
Assessing endothelial dysfunction in adolescents and young adults with type 1 diabetes mellitus using a non-invasive heat stimulus. Pediatr Diabetes (2014) 0.80
Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. J Sleep Res (2013) 0.80
Inconsistent Correlation Between Carotid Artery Intima-Media Thickness and Peripheral Arterial Tonometry: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Medicine (Baltimore) (2015) 0.80
Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab (2014) 0.80
New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction. Curr Heart Fail Rep (2014) 0.80
Selection of cell-type specific antibodies on tissue-sections using phage display. J Cell Mol Med (2015) 0.80
The Evaluation of the Impact of Age, Skin Tags, Metabolic Syndrome, Body Mass Index, and Smoking on Homocysteine, Endothelin-1, High-sensitive C-reactive Protein, and on the Heart. Indian J Dermatol (2013) 0.80
Impaired vasomotor function induced by the combination of hypertension and hypercholesterolemia. J Am Soc Hypertens (2013) 0.79
Impaired endothelial function in pediatric patients with turner syndrome and healthy controls: a case-control study. Int J Pediatr Endocrinol (2012) 0.79
Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers. Vasc Health Risk Manag (2008) 0.79
Pro-contractile effects of perivascular fat in health and disease. Br J Pharmacol (2017) 0.78
Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int (2015) 0.78
Effect of repeatedly heated palm olein on blood pressure-regulating enzymes activity and lipid peroxidation in rats. Malays J Med Sci (2012) 0.78
Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies. Front Physiol (2016) 0.78
L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging. J Cardiovasc Pharmacol Ther (2010) 0.78
Association of digital vascular function with cardiovascular risk factors: a population study. BMJ Open (2014) 0.78
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Ther Adv Urol (2009) 0.78
Age-associated downregulation of vasohibin-1 in vascular endothelial cells. Aging Cell (2016) 0.78
Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. Am J Transl Res (2016) 0.78
Thrombin Generation in Acute Ischaemic Stroke. Stroke Res Treat (2016) 0.77
Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and Women. PLoS One (2015) 0.77
Energy restriction and exercise modulate angiopoietins and vascular endothelial growth factor expression in the cavernous tissue of high-fat diet-fed rats. Asian J Androl (2011) 0.77
Hypercholesterolemia blunts the oxidative stress elicited by hypertension in venules through angiotensin II type-2 receptors. Microvasc Res (2016) 0.77
Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome. Hypertens Pregnancy (2014) 0.77
A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women. Eur J Nutr (2015) 0.77
Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertension. PLoS One (2010) 0.77
The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol Rev (2012) 0.77
Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets. Cardiovasc Diabetol (2016) 0.77
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis. Oxid Med Cell Longev (2015) 0.77
High Dietary Fructose Intake on Cardiovascular Disease Related Parameters in Growing Rats. Nutrients (2016) 0.76
Is reversal of endothelial dysfunction still an attractive target in modern cardiology? World J Cardiol (2014) 0.76
Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study. J Endocrinol Invest (2015) 0.76
Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index. Br J Clin Pharmacol (2005) 0.76
Early life stress in male mice induces superoxide production and endothelial dysfunction in adulthood. Am J Physiol Heart Circ Physiol (2016) 0.76
Low-level laser irradiation effect on endothelial cells under conditions of hyperglycemia. Lasers Med Sci (2016) 0.75
Microvascular dysfunction in schizophrenia: a case-control study. NPJ Schizophr (2015) 0.75
Chinese innovation in cardiovascular drug discovery. Br J Pharmacol (2015) 0.75
Impact of Cigarette Smoking: a 3-Year Clinical Outcome of Vasospastic Angina Patients. Korean Circ J (2016) 0.75
Assessments of endothelial function and arterial stiffness are reproducible in patients with COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.75
The cardioprotective power of leaves. Arch Med Sci (2015) 0.75
Measurement of brachial artery endothelial function using a standard blood pressure cuff. Physiol Meas (2015) 0.75
Can a simple fingertip temperature measurement predict a cardiac event? Int J Cardiovasc Imaging (2009) 0.75
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes. Integr Blood Press Control (2010) 0.75
Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. J Diabetes Res (2013) 0.75
Effect of huanglian jiedu decoction on thoracic aorta gene expression in spontaneous hypertensive rats. Evid Based Complement Alternat Med (2014) 0.75
The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil. Int J Impot Res (2016) 0.75
Measurement of endothelial dysfunction via peripheral arterial tonometry predicts vasculogenic erectile dysfunction. Int J Impot Res (2014) 0.75
The influence of endothelial function and myocardial ischemia on peak oxygen consumption in patients with coronary artery disease. Int J Vasc Med (2012) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care (2012) 21.62
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2005) 11.91
Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985) (2006) 11.52
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med (2009) 5.34
A prescription for better prescribing. BMJ (2006) 5.31
Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol (2005) 5.18
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med (2006) 5.18
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Treatment of periodontitis and endothelial function. N Engl J Med (2007) 4.83
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation (2005) 4.69
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation (2003) 4.61
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr (2007) 4.34
Clinical pharmacology--too young to die? Lancet (2006) 4.32
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation (2010) 4.12
Statins and the risk of cancer after heart transplantation. Circulation (2012) 4.06
Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology (2011) 4.06
Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension (2008) 3.99
Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation (2002) 3.83
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol (2008) 3.52
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens (2011) 3.50
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol (2003) 3.37
The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol (2004) 3.35
Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 3.34
Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension (2008) 3.32
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet (2007) 3.20
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest (2014) 3.10
The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients. J Am Coll Cardiol (2006) 2.96
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One (2010) 2.94
Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension (2007) 2.94
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 2.90
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension (2013) 2.82
Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension (2010) 2.81
Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation (2007) 2.75
Cohort profile: updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research. Int J Epidemiol (2011) 2.75
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity (2013) 2.74
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes (2007) 2.73
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation (2005) 2.69
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Natural Course of Paravalvular Regurgitation After Implantation of the Self-Expanding CoreValve: Insights From Serial TEE Measurements. J Invasive Cardiol (2015) 2.62
Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens (2006) 2.61
Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol (2003) 2.59
Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension (2009) 2.58
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care (2005) 2.53
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology (2007) 2.50
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation (2002) 2.45
Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation (2008) 2.45
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44
High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation (2003) 2.44
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol (2004) 2.43
Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail (2012) 2.41
Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol (2011) 2.40
An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension (2010) 2.40
Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation (2008) 2.39
Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science (2004) 2.38
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension (2009) 2.38
C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol (2004) 2.37
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest (2011) 2.37
Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension (2004) 2.33
A spoonful of sugar? Tomorrow's doctors 2002. Br J Clin Pharmacol (2002) 2.32
Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension (2011) 2.32
Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension (2004) 2.31
Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation (2002) 2.30